Approved comparison material connected to this topic.
13 total recordsSource comparisons are presented without a generated winner.
Study dosage answers the question: “What did researchers evaluate?” It does not answer: “What should a specific person take?” Personal medical decisions depend on diagnosis, indication, regulatory status, prod…
LL-37 vs Thymosin Alpha-1 — Peptide Comparison LL-37 vs Thymosin Alpha-1 — compare dosing, benefits, safety profiles, side effects, and how they stack. See which peptide is right for you. At a Glance Dose Rang…
Lentinan vs Thymosin Alpha-1 — Peptide Comparison Lentinan vs Thymosin Alpha-1 — compare dosing, benefits, safety profiles, side effects, and how they stack. See which peptide is right for you. At a Glance Dos…
Bestatin (Ubenimex) vs Thymosin Alpha-1 — Peptide Comparison Bestatin (Ubenimex) vs Thymosin Alpha-1 — compare dosing, benefits, safety profiles, side effects, and how they stack. See which peptide is right fo…
Imunofan vs Thymosin Alpha-1 — Peptide Comparison Imunofan vs Thymosin Alpha-1 — compare dosing, benefits, safety profiles, side effects, and how they stack. See which peptide is right for you. At a Glance Dos…
Pidotimod vs Thymosin Alpha-1 — Peptide Comparison Pidotimod vs Thymosin Alpha-1 — compare dosing, benefits, safety profiles, side effects, and how they stack. See which peptide is right for you. At a Glance D…
Dose Range Bestatin (Ubenimex) 10–100 mg Thymosin Alpha-1 1.6–3.2 mg Frequency Once daily Twice weekly Administration Oral (capsule) Subcutaneous injection Cycle Length 12+ weeks 8-12 weeks Onset Speed Moderat…
Dose Range Imunofan 50–100 mcg Thymosin Alpha-1 1.6–3.2 mg Frequency Once daily Twice weekly Administration Subcutaneous injection Cycle Length 8-12 weeks Onset Speed Rapid (hours to days) Moderate (1-2 weeks)…
Dose Range LL-37 0.5–1.6 mg/mL (topical) Thymosin Alpha-1 1.6–3.2 mg Frequency Once daily Twice weekly Administration Topical application (wound healing) Subcutaneous injection Cycle Length 12+ weeks 8-12 week…
Dose Range Lentinan 2–10 mg Thymosin Alpha-1 1.6–3.2 mg Frequency Once weekly Twice weekly Administration Intravenous infusion Subcutaneous injection Cycle Length 8-12 weeks Onset Speed Moderate (1-2 weeks) Ev…
Dose Range Pidotimod 400–800 mg Thymosin Alpha-1 1.6–3.2 mg Frequency Multiple times daily Twice weekly Administration Oral (tablet) Subcutaneous injection Cycle Length 12+ weeks 8-12 weeks Onset Speed Moderat…
Synthetic thymosin alpha-1 peptide—produced through solid-phase peptide synthesis (SPPS) using Fmoc chemistry—is a single, chemically defined molecule with the exact 28-amino-acid sequence Ser-Asp-Ala-Ala-Val-…
Chronic Hepatitis B/C Enhances Th1 cytokine production (IFN-gamma, IL-2), increases CD4+ and CD8+ T-cell counts, improves viral clearance when combined with antivirals 1.6mg subcutaneous twice weekly for 24–48…